Plasma protein oxidation and total antioxidant power in premenstrual dysphoric disorder and menstruating young adult females

Eans Tara Tuladhar, A. Kamath, Anjali Rao

Research output: Contribution to journalArticle

Abstract

Purpose: Oxidative damage has been associated with many human diseases encompassing mood affective disorders. Premenstrual dysphoric disorder (PMDD) has features which are similar to these, along with physical symptoms of stress. The purpose of the present study was, to assess whether oxidative stress has any role in PMDD. Method: Female subjects suffering from PMDD, in the age group of 20-24 years, were compared to their eumennorhic counterparts and also with those with premenstrual syndrome (PMS), in the follicular phase and in the late luteal phase for the ferric reducing antioxidant power of plasma (FRAP), plasma protein thiol (PPT) and protein carbonyl (PPC) levels. Results: There were no significant changes in the FRAP and PPC levels in the controls, in the PMS and the PMDD groups, but PPT levels decreased significantly in the luteal phase of the PMS (P=0.015) and the PMDD groups (P= 0.018) when compared to those in the follicular phase. Besides, PPT levels exhibited a significant increase (P=0.015) in the follicular phase of the PMDD subjects. Conclusion: A marked decrease in PPT levels in the luteal phase of the PMS and the PMDD groups may be due to the pro-oxidant nature of oestrogen - active in this phase of PMS, leading to the consumption of the sacrificial antioxidant - protein thiol. Further, to compensate this loss, a large reserve of PPT gets accumulated in the follicular phase of the PMDD group, thus indicating a dynamic turnover of this antioxidant between the two phases.

Original languageEnglish
Pages (from-to)3410-3413
Number of pages4
JournalJournal of Clinical and Diagnostic Research
Volume4
Issue number6
Publication statusPublished - 2010

Fingerprint

Sulfhydryl Compounds
Blood Proteins
Young Adult
Premenstrual Syndrome
Antioxidants
Oxidation
Follicular Phase
Luteal Phase
Mood Disorders
Plasmas
Proteins
Oxidative stress
Premenstrual Dysphoric Disorder
Power (Psychology)
Reactive Oxygen Species
Estrogens
Oxidative Stress
Age Groups

All Science Journal Classification (ASJC) codes

  • Medicine(all)
  • Clinical Biochemistry

Cite this

@article{2885a17ea3a6455b9fa58872ae033590,
title = "Plasma protein oxidation and total antioxidant power in premenstrual dysphoric disorder and menstruating young adult females",
abstract = "Purpose: Oxidative damage has been associated with many human diseases encompassing mood affective disorders. Premenstrual dysphoric disorder (PMDD) has features which are similar to these, along with physical symptoms of stress. The purpose of the present study was, to assess whether oxidative stress has any role in PMDD. Method: Female subjects suffering from PMDD, in the age group of 20-24 years, were compared to their eumennorhic counterparts and also with those with premenstrual syndrome (PMS), in the follicular phase and in the late luteal phase for the ferric reducing antioxidant power of plasma (FRAP), plasma protein thiol (PPT) and protein carbonyl (PPC) levels. Results: There were no significant changes in the FRAP and PPC levels in the controls, in the PMS and the PMDD groups, but PPT levels decreased significantly in the luteal phase of the PMS (P=0.015) and the PMDD groups (P= 0.018) when compared to those in the follicular phase. Besides, PPT levels exhibited a significant increase (P=0.015) in the follicular phase of the PMDD subjects. Conclusion: A marked decrease in PPT levels in the luteal phase of the PMS and the PMDD groups may be due to the pro-oxidant nature of oestrogen - active in this phase of PMS, leading to the consumption of the sacrificial antioxidant - protein thiol. Further, to compensate this loss, a large reserve of PPT gets accumulated in the follicular phase of the PMDD group, thus indicating a dynamic turnover of this antioxidant between the two phases.",
author = "Tuladhar, {Eans Tara} and A. Kamath and Anjali Rao",
year = "2010",
language = "English",
volume = "4",
pages = "3410--3413",
journal = "Journal of Clinical and Diagnostic Research",
issn = "2249-782X",
publisher = "Journal of Clinical and Diagnostic Research",
number = "6",

}

Plasma protein oxidation and total antioxidant power in premenstrual dysphoric disorder and menstruating young adult females. / Tuladhar, Eans Tara; Kamath, A.; Rao, Anjali.

In: Journal of Clinical and Diagnostic Research, Vol. 4, No. 6, 2010, p. 3410-3413.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Plasma protein oxidation and total antioxidant power in premenstrual dysphoric disorder and menstruating young adult females

AU - Tuladhar, Eans Tara

AU - Kamath, A.

AU - Rao, Anjali

PY - 2010

Y1 - 2010

N2 - Purpose: Oxidative damage has been associated with many human diseases encompassing mood affective disorders. Premenstrual dysphoric disorder (PMDD) has features which are similar to these, along with physical symptoms of stress. The purpose of the present study was, to assess whether oxidative stress has any role in PMDD. Method: Female subjects suffering from PMDD, in the age group of 20-24 years, were compared to their eumennorhic counterparts and also with those with premenstrual syndrome (PMS), in the follicular phase and in the late luteal phase for the ferric reducing antioxidant power of plasma (FRAP), plasma protein thiol (PPT) and protein carbonyl (PPC) levels. Results: There were no significant changes in the FRAP and PPC levels in the controls, in the PMS and the PMDD groups, but PPT levels decreased significantly in the luteal phase of the PMS (P=0.015) and the PMDD groups (P= 0.018) when compared to those in the follicular phase. Besides, PPT levels exhibited a significant increase (P=0.015) in the follicular phase of the PMDD subjects. Conclusion: A marked decrease in PPT levels in the luteal phase of the PMS and the PMDD groups may be due to the pro-oxidant nature of oestrogen - active in this phase of PMS, leading to the consumption of the sacrificial antioxidant - protein thiol. Further, to compensate this loss, a large reserve of PPT gets accumulated in the follicular phase of the PMDD group, thus indicating a dynamic turnover of this antioxidant between the two phases.

AB - Purpose: Oxidative damage has been associated with many human diseases encompassing mood affective disorders. Premenstrual dysphoric disorder (PMDD) has features which are similar to these, along with physical symptoms of stress. The purpose of the present study was, to assess whether oxidative stress has any role in PMDD. Method: Female subjects suffering from PMDD, in the age group of 20-24 years, were compared to their eumennorhic counterparts and also with those with premenstrual syndrome (PMS), in the follicular phase and in the late luteal phase for the ferric reducing antioxidant power of plasma (FRAP), plasma protein thiol (PPT) and protein carbonyl (PPC) levels. Results: There were no significant changes in the FRAP and PPC levels in the controls, in the PMS and the PMDD groups, but PPT levels decreased significantly in the luteal phase of the PMS (P=0.015) and the PMDD groups (P= 0.018) when compared to those in the follicular phase. Besides, PPT levels exhibited a significant increase (P=0.015) in the follicular phase of the PMDD subjects. Conclusion: A marked decrease in PPT levels in the luteal phase of the PMS and the PMDD groups may be due to the pro-oxidant nature of oestrogen - active in this phase of PMS, leading to the consumption of the sacrificial antioxidant - protein thiol. Further, to compensate this loss, a large reserve of PPT gets accumulated in the follicular phase of the PMDD group, thus indicating a dynamic turnover of this antioxidant between the two phases.

UR - http://www.scopus.com/inward/record.url?scp=78650577212&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650577212&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:78650577212

VL - 4

SP - 3410

EP - 3413

JO - Journal of Clinical and Diagnostic Research

JF - Journal of Clinical and Diagnostic Research

SN - 2249-782X

IS - 6

ER -